Views Navigation

Event Views Navigation


Preparing Europe for Novel Psychedelic-Assisted Therapies: Launch of PAREA

We all know the feeling of helplessness when we are unable to help people – often our loved ones – who are affected by mental health conditions, addictions or neurological ailments, including chronic pain. We know that mental healthcare is in crisis and we don’t have enough options to truly help many people in need. [...]

8th Congress of the European Academy of Neurology


  The 8th Congress of the European Academy of Neurology (EAN) will take place in Vienna (Austria) on June 25 to 28, 2022. Our ambition is that the 8th EAN Congress will be a truly pan-European meeting, in a fact the premier meeting of 2022, bringing together neurologists and neuro-scientists to network and to exchange knowledge [...]

EBC at EAN Congress 2022

EBC was pleased to be part of this year's Congress of the European Academy of Neurology, which took place in person on 25-28 June 2022 in Vienna, Austria. Alongside an Exhibition Stand in the EAN Neurohood, EBC had a Special Session take place on 28 June at 13:00-14:30 (Room Berlin), celebrating 20 Years of Advocacy [...]

11th European Conference on Rare Diseases & Orphan Products

The European Conference on Rare Diseases & Orphan Products (ECRD) is recognised globally as the largest, patient-led rare disease event in which collaborative dialogue, learning and conversation takes place, forming the groundwork to shape goal-driven rare disease policies and allow for important and innovative discussions on a national and an international level to take place. [...]

XVI Workshop on Neurobiology of Epilepsy (WONOEP 2022)

WONOEP XVI, a satellite event of the 14th ILAE European Epilepsy Congress, will take place at Talloires, France. The main topic of WONOEP XVI is “Early onset epilepsies: neurobiology and novel therapeutic strategies”. The overall purpose of WONOEP XVI will be to provide novel insights on early onset epilepsies, underlying neurobiology and strategies towards the development of new treatments. More information here: [...]

FENS Forum 2022


The FENS Forum is Europe’s largest international neuroscience conference, covering all domains in modern brain research from basic to translational research. The Forum represents a unique opportunity for neuroscientists from around the world to gather together and enjoy excellent science in one of Europe’s most vibrant cities. Organised by FENS in partnership with the French [...]

FENS Forum 2022 Advocacy Training Workshop

We are delighted to invite you to the FENS Forum 2022 Advocacy Training Workshop ⁠— a hands-on advocacy workshop for FENS National Societies and National Brain Councils ⁠— taking place on Sunday, 10 July 2022, from 14:30-15:45 in Hall I (level 7.3). Featured speakers will include Jean-Antoine Girault (FENS President), Kirk Leech (Executive Director, European [...]

The European Brain Research area: Building a Brain Health Partnership

Paris Expo Porte de Versailles, Pavillon 7, Hall B

The European Brain Research Area (EBRA) will host a Special Interest Event at the upcoming FENS Forum 2022 on 11 July at 12:00-12:45 in Hall B. Brain research is a rapidly evolving field and increasingly at the forefront of science. The EU and its Member States have made considerable investment in brain research leading to [...]

Brain capital and the young generation

FENS Forum 2022 - Special Interest Session & Networking Event: “Brain capital and the young generation”  Tuesday 12 July 2022 at 18:45-20:30, Hall G Session moderated by FENS President, Prof. Jean Antoine Girault, and EBC President, Prof. Wolfgang Oertel   Mental health disorders cannot be ignored, nor can their devastating impact on families, communities, and [...]

Overcoming roadblocks: Making psychedelic-assisted therapy a reality

Learn about when and how psychedelic-assisted therapy becomes a reality. What are the legislative and regulatory roadblocks, and how Chris Koddermann (ITPRI - Reschedule Psilocybin), Amy Emerson (MAPS PBC), Tadeusz Hawrot (PAREA - Psychedelic Access and Research European Alliance) and Graham Pechenik (Calyx Law) are taking them down? When will psychedelic-assisted therapy become a reality [...]